Paulo Jacob Silva

This paper develops a broad-spectrum antiviral compound that inhibits multiple respiratory viruses in human airway models and in vivo.

This study develops CD-SA, a β-cyclodextrin-based nanomaterial that acts as a potent broad-spectrum antiviral against influenza A and B viruses, showing higher efficacy than Oseltamivir in ex vivo and in vivo tests.

This paper introduces gold nanoparticles labeled with 11-mercapto-1-undecanesulfonate to visualize and characterize amyloid polymorphism using cryo-EM, revealing structural differences between in vivo and in vitro amyloid fibrils.